Drug Discovery Leaders Warn U.S. Cuts Endanger AI Edge
As Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
Combining the ladder with index funds adds diversification and steadier cash flow, helping manage sequence of return risk over retirement.
28,657 articlesAs Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
A trusted market voice pivots from saying there’s no bubble to warning of growing chaos as IPO activity accelerates a...
In a volatile market, Procter & Gamble’s decades-long dividend growth and reliable cash flow position it as a stable ...
Two 2x levered SMCI ETFs are delivering divergent outcomes in mid-2026 as AI server demand fluctuates and governance ...
CME Group has sued the CFTC over how perpetual futures are classified, triggering a formal cftc, request public comme...
Manchester’s mayor is emerging as Labour’s strongest northern voice in a high-stakes leadership contest. This report ...
NASA slows plans for Artemis II after engineers find a helium-flow issue in the upper stage, forcing a rollback to th...
Bitcoin rides a volatility wave as geopolitics intersect with liquidity cycles. The US appears to be the only market ...
Cryptio has closed a $45 million Series B to scale its enterprise crypto accounting platform, aiming to help large fi...
As defense budgets stabilize and technology explodes, investors are re-pricing defense names. This piece examines why...
The White House rejected Elon Musk’s public offer to fund TSA salaries during the budget stalemate, setting off a fre...
Millrose Properties marks its first year as an independent REIT with solid Q1 2026 earnings, expanding its builder ne...